Health Care & Life Sciences » Biotechnology | NanoString Technologies Inc.

NanoString Technologies Inc. | Mutual Funds

Mutual Funds that own NanoString Technologies Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
ARK Innovation ETF
2,538,123
8.52%
-20,700
2.9%
09/05/2018
Vanguard Total Stock Market Index Fund
844,989
2.84%
181,798
0%
07/31/2018
ARK Genomic Revolution Multi Sector ETF
673,839
2.25%
3,762
3.54%
09/05/2018
Polar Capital Funds Plc - Biotechnology Fund
500,000
1.68%
0
1.63%
07/31/2018
iShares Russell 2000 ETF
455,071
1.53%
-243
0.02%
09/06/2018
Homestead Small Company Stock Fund
395,418
1.33%
0
0.54%
03/29/2018
iShares Nasdaq Biotechnology ETF
342,561
1.14%
-4,473
0.06%
09/06/2018
Vanguard Extended Market Index Fund
329,851
1.11%
77,600
0.01%
07/31/2018
Neuberger Berman Intrinsic Value Fund
325,300
1.09%
-23,700
0.65%
06/30/2018
db x-trackers MSCI USA TRN Index ETF
312,052
1.05%
0
0.15%
08/30/2018

About NanoString Technologies

View Profile
Address
530 Fairview Avenue North
Seattle Washington 98109
United States
Employees -
Website http://www.nanostring.com
Updated 07/08/2019
NanoString Technologies, Inc. engages in the provision of life science tools for translational research and molecular diagnostic products. It offers analysis solutions, gene expression panels, protein assays, DNA Assaya, miRNA assays, vantage 3D assays, custom solutions, sample prep and nCounter consumables, and nDesign gateway. The company was founded by Amber Ratcliffe, Krassen Dimitrov, and Dwayne Dunaway on June 20, 2003 and is headquartered in Seattle, WA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.